Literature DB >> 6307974

Mapping of the gene specifying aminoglycoside 3'-phosphotransferase II on the Pseudomonas aeruginosa chromosome.

M Okii, S Iyobe, S Mitsuhashi.   

Abstract

We examined the aminoglycoside inactivation enzymes in Pseudomonas aeruginosa strains, seven clinical isolates and seven laboratory strains without plasmids. All strains were found to possess the enzyme aminoglycoside 3'-phosphotransferase II [APH(3')-II]. We isolated an APH(3')-II-deficient mutant from a PAO strain by mutagenesis with N-methyl-N'-nitro-N-nitrosoguanidine. By plasmid (FP5 or R68.45)-mediated conjugation, we determined the locus of the gene specifying the APH(3')-II between trp-6 and pro-82 on the PAO chromosome and designated this gene aphA. It was concluded that the intrinsic resistance of P. aeruginosa to kanamycins, neomycins, paromomycins, ribostamycin, and butirosins was due to this newly determined gene.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307974      PMCID: PMC217734          DOI: 10.1128/jb.155.2.643-649.1983

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  31 in total

1.  Two enzymes which phosphorylate neomycin and kanamycin in Escherichia coli strains carrying R factors.

Authors:  M Brzezinska; J Davies
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

2.  A new enzyme in Escherichia coli carrying R-factor phosphorylating 3'-hydroxyl of butirosin A, kanamycin, neamine and ribostamycin.

Authors:  M Yagisawa; H Yamamoto; H Naganawa; S Kondo; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1972-12       Impact factor: 2.649

3.  Isolation of kanamycin and paromamine inactivated by E. coli carrying R factor.

Authors:  S Kondo; M Okanishi; R Utahara; K Maeda; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1968-01       Impact factor: 2.649

4.  Aminoglycoside antibiotics: inactivation by phosphorylation in Escherichia coli carrying R factors.

Authors:  B Ozanne; R Benveniste; D Tipper; J Davies
Journal:  J Bacteriol       Date:  1969-11       Impact factor: 3.490

5.  FP5 factor, an undescribed sex factor of Pseudomonas aeruginosa.

Authors:  H Matsumoto; T Tazaki
Journal:  Jpn J Microbiol       Date:  1973-09

6.  Genetic analysis of phenylalanine-responding mutants of Pseudomonas aeruginosa.

Authors:  J A Waltho
Journal:  J Bacteriol       Date:  1972-12       Impact factor: 3.490

7.  Adenylyldideoxykanamycin B, a product of the inactivation of dideoxykanamycin B by Escherichia coli carrying R factor.

Authors:  M Yagisawa; H Naganawa; S Kondo; M Hamada; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1971-12       Impact factor: 2.649

8.  Aminoglycoside 3'-phosphotransferases I and II in Pseudomonas aeruginosa.

Authors:  Y Matsuhashi; M Yagisawa; S Kondo; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1975-06       Impact factor: 2.649

9.  Acetylation of amikacin, a new semisynthetic antibiotic, by Pseudomonas aeruginosa carrying an R factor.

Authors:  H Kawabe; T Naito; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

10.  Transferable drug resistance in Pseudomonas aeruginosa.

Authors:  L E Bryan; H M Van Den Elzen; J T Tseng
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

View more
  22 in total

1.  The pvc gene cluster of Pseudomonas aeruginosa: role in synthesis of the pyoverdine chromophore and regulation by PtxR and PvdS.

Authors:  A Stintzi; Z Johnson; M Stonehouse; U Ochsner; J M Meyer; M L Vasil; K Poole
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

2.  Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.

Authors:  Catherine Llanes; Didier Hocquet; Christelle Vogne; Dounia Benali-Baitich; Catherine Neuwirth; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  In vitro activity of E1040 against imipenem-resistant Pseudomonas aeruginosa strains.

Authors:  M Watanabe; E Inoue; K Katsu; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

Review 4.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Isolation of a Tn501 insertion mutant lacking porin protein P of Pseudomonas aeruginosa.

Authors:  K Poole; R E Hancock
Journal:  Mol Gen Genet       Date:  1986-03

6.  Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance.

Authors:  X Z Li; L Zhang; K Poole
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

7.  Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.

Authors:  Farid El'Garch; Katy Jeannot; Didier Hocquet; Catherine Llanes-Barakat; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

8.  Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.

Authors:  K Hirai; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

9.  Characterization of the Pseudomonas aeruginosa recA analog and its protein product: rec-102 is a mutant allele of the P. aeruginosa PAO recA gene.

Authors:  T A Kokjohn; R V Miller
Journal:  J Bacteriol       Date:  1987-04       Impact factor: 3.490

10.  Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.

Authors:  K Poole; K Krebes; C McNally; S Neshat
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.